Company profile
SpecterOps
BloodHound Enterprise identity attack-path management across AD, Entra ID, Okta, AWS, and GitHub.
- Status
- PrivateListed on CyberMerge Startup Radar (private vendors), snapshot Nov 12, 2026
- Valuation
- Undisclosed
- Latest funding
- Undisclosed
- HQ
- Alexandria, VA / US (Startup Radar)
- Last updated
Categories
Funding & valuation
Funding: Undisclosed — no round recorded in the CyberMerge Funding Tracker.
Latest signals
Competitors
Same-category peers from CyberMerge Research maps, Startup Radar and What's The Use tags.
- SpyCloudPrivateRecaptured-identity intelligence: exposed credentials, session cookies, and ATO prevention for ITDR.
- NebulockPrivateHunt-first contextual security analytics across endpoint, identity, cloud, network, and SaaS.
- FlarePrivateIdentity-first cyber threat intelligence and exposure management (stealer logs, dark web, CTI workflows).
- Hudson RockPrivateInfostealer / cybercrime intelligence for compromised-employee and vendor detection.
- VantaPrivateAutomated trust and compliance platform that continuously collects evidence and monitors controls for SOC 2,…
- CriblPrivateTelemetry / security data pipeline (SIEM-adjacent) expanding into SOC via CardinalOps detection engineering…
- RecoPrivateIdentity/SaaS graph for apps, AI agents, and NHIs: discovers agents, maps reach to…
- IslandPrivateEnterprise browser plus AI Protect: prompts, tool calls, Island MCP Gateway — agentic control plane for…
- Abstract SecurityPrivateStreaming-first agentic SIEM: a security data pipeline normalizes and enriches events with identity,…
- AnvilogicPrivateAgentic detection engineering and Detection-as-Code across SIEM and data lakes.
- CogentPrivateAI agents for vulnerability management: tie each finding to the asset, owner and business context, rank what…
- ThreatBookPrivateChina-origin NDR / threat detection platform; Gartner NDR Niche Player (2025 MQ).
Figures appear only as recorded in CyberMerge data, with source and date. “Undisclosed” means no published figure in our data. Editorial, not investment advice. Last updated . Spot an error? Tell the desk.
